Company: BCS
Filing Date: 2025-02-19
Form Type: 424B2
Source: 0001193125-25-029335
Chunk: 43

Company: BARCLAYS PLC
Filing Date: 2025-02-19
Form: 424B2
Chunk 43
---
 Interest | Barclays Capital Inc., the Sole Structuring Adviser and Sole Bookrunner, is an affiliate of Barclays PLC and, as such, is deemed to have a “conflict of interest” in this offering within the meaning of Rule 5121 (or any successor rule 
 thereto) (“Rule 5121”) of the Financial Industry Regulatory Authority, Inc. (“FINRA”).                                                                                                                                                    |

| Consequently, this offering is being conducted in compliance with the provisions of Rule 5121. Barclays Capital Inc. is not permitted to sell any notes in this offering to an account over which it exercises 
 discretionary authority without the prior specific written approval of the account holder. For more information, see “Underwriting (Conflicts of Interest)—Conflicts of Interest.”                             |

CUSIP 20 notes: 20 notes: 20 notes: 20 floating rate notes: 20 floating rate notes: ISIN 20 notes: 20 notes: 20 notes: 20 floating rate notes: 20 floating rate notes:

S-27

Common Code 20 notes: 20 notes: 20 notes: 20 floating rate notes: 20 floating rate notes:

| Listing and Trading | We will apply to list the notes on the NYSE. Trading on the NYSE is expected to begin within 30 days of the initial delivery of the notes. |

| Trustee and Paying Agent | The Bank of New York Mellon, London Branch, 160 Queen Victoria Street, London, EC4V 4LA, U.K., will act as the trustee and initial paying agent for the notes. |

| Timing and Delivery | We currently expect delivery of the notes to occur on     , 2025. |

| Further Issues | We may, without the consent of the holders of the notes, issue additional notes having the same ranking and same interest rate, Maturity Date, redemption terms and other terms as any series of notes described in this prospectus supplement except   
 for the price to the public and issue date. Any such additional notes, together with the notes of the same series offered by this prospectus supplement, will constitute a single series of such securities under the Indenture. There is no limitation 
 on the amount of notes or other debt securities that we may issue under the Indenture.                                                                                                                                                                  |

| Use of Proceeds | We intend to use the proceeds of the offering for general corporate purposes of the Issuer and its subsidiaries and/or the Group and to strengthen further